11.64
-3.1(-21.03%)
Currency In USD
| Previous Close | 14.74 |
| Open | 12.79 |
| Day High | 13.3 |
| Day Low | 11.51 |
| 52-Week High | 29.12 |
| 52-Week Low | 11.51 |
| Volume | 222,053 |
| Average Volume | 70,700 |
| Market Cap | 166.93M |
| PE | -19.4 |
| EPS | -0.6 |
| Moving Average 50 Days | 15.18 |
| Moving Average 200 Days | 19.57 |
| Change | -3.1 |
If you invested $1000 in Anika Therapeutics, Inc. (ANIK) 10 years ago, it would be worth $339.75 as of May 10, 2025 at a share price of $11.64. Whereas If you bought $1000 worth of Anika Therapeutics, Inc. (ANIK) shares 5 years ago, it would be worth $372.24 as of May 10, 2025 at a share price of $11.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Anika to Participate in the Sidoti Virtual Investor Conference
GlobeNewswire Inc.
May 07, 2025 8:01 PM GMT
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
GlobeNewswire Inc.
Apr 25, 2025 1:00 PM GMT
BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before th
Anika Completes Divestiture of Parcus Medical
GlobeNewswire Inc.
Mar 07, 2025 11:00 AM GMT
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions PortfolioBEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global